AMVIREX

Serial Number 76070328
602

Registration Progress

Application Filed
Jun 14, 2000
Under Examination
Aug 21, 2001
Approved for Publication
May 16, 2001
Published for Opposition
May 29, 2001
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: AMVIREX
Previous Owner: Squires, Meryl
Classes: 005

Trademark Image

AMVIREX

Basic Information

Serial Number
76070328
Filing Date
June 14, 2000
Published for Opposition
May 29, 2001
Abandonment Date
September 24, 2002
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Dec 3, 2002
Classes
005

Rights Holder

Squires, Meryl

01
Address
2 Gooselake Drive
Barrington Hills, IL 60010

Ownership History

Squires, Meryl

Original Applicant
01
Barrington Hills, IL

Squires, Meryl

Owner at Publication
01
Barrington Hills, IL

Legal Representation

Attorney
Thomas W. Tolpin

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
Apr 23, 2003 MAIL I PAPER RECEIVED Loading...
Dec 3, 2002 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 22, 2002 CNRT O NON-FINAL ACTION MAILED Loading...
Mar 13, 2002 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 11, 2002 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 21, 2002 IUAF S USE AMENDMENT FILED Loading...
Feb 27, 2002 MAIL I PAPER RECEIVED Loading...
Aug 21, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 29, 2001 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 16, 2001 NPUB O NOTICE OF PUBLICATION Loading...
Jan 15, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 3, 2001 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Dec 28, 2000 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 8, 2000 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATION WITH ANTIVIRAL AND/OR ANTIMICROBIAL PROPERTIES FOR USE IN THE TREATMENT OF VIRAL INFLUENZA (FLU), SHINGLES, HERPES (HERPES SIMPLEX VIRUS), VARICELLA-ZOSTER VIRUS (HERPES ZOSTER), GENICULATE ZOSTER, HERPES KERATITIS, CHICKEN POX, CYTOMEGALOVIRUS, EPSTEIN-BARR, PAPILLOMA VIRUS, VIRAL PARAINFLUENZA, ADENOVIRUS, VIRAL ENCEPHALITIS, VIRAL MENINGITIS, ARBOVIRUS, ARENAVIRUS, PICORNAVIRUS, CORONAVIRUS, SYNTIAL VIRUS, VIRAL INFECTIONS, COMMON COLDS CAUSED BY VIRUSES, HUMAN IMMUNODEFICIENCY VIRUS (HIV), GINGIVOSTOMATITIS, ROSEOLA INFANTUM, ORGAN TRANSPLANT REJECTION, PNEUMONIA, INFECTIOUS MONONUCLEOSIS, UVEITIS, RETINITIS, HUMAN PAPILLOMA VIRUS, CERVICAL CARCINOMA, VAGINAL CARCINOMA, VULVOVAGINITIS, HUMAN HERPES IV, ANF KAPOSI'S SARCOMA
First Use Anywhere: Feb 19, 2002
First Use in Commerce: Feb 19, 2002

Classification

International Classes
005